BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 25555911)

  • 1. Proteolytic regulation of epithelial sodium channels by urokinase plasminogen activator: cutting edge and cleavage sites.
    Ji HL; Zhao R; Komissarov AA; Chang Y; Liu Y; Matthay MA
    J Biol Chem; 2015 Feb; 290(9):5241-55. PubMed ID: 25555911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Urokinase-type plasminogen activator (uPA) is not essential for epithelial sodium channel (ENaC)-mediated sodium retention in experimental nephrotic syndrome.
    Bohnert BN; Daiminger S; Wörn M; Sure F; Staudner T; Ilyaskin AV; Batbouta F; Janessa A; Schneider JC; Essigke D; Kanse S; Haerteis S; Korbmacher C; Artunc F
    Acta Physiol (Oxf); 2019 Dec; 227(4):e13286. PubMed ID: 31006168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of epithelial sodium channels in urokinase plasminogen activator deficiency.
    Chen Z; Zhao R; Zhao M; Liang X; Bhattarai D; Dhiman R; Shetty S; Idell S; Ji HL
    Am J Physiol Lung Cell Mol Physiol; 2014 Oct; 307(8):L609-17. PubMed ID: 25172911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of plasminogen activator inhibitor-1 by urokinase in lung epithelial cells.
    Shetty S; Bdeir K; Cines DB; Idell S
    J Biol Chem; 2003 May; 278(20):18124-31. PubMed ID: 12642587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping allosteric linkage to channel gating by extracellular domains in the human epithelial sodium channel.
    Shobair M; Popov KI; Dang YL; He H; Stutts MJ; Dokholyan NV
    J Biol Chem; 2018 Mar; 293(10):3675-3684. PubMed ID: 29358325
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural basis for recognition of urokinase-type plasminogen activator by plasminogen activator inhibitor-1.
    Lin Z; Jiang L; Yuan C; Jensen JK; Zhang X; Luo Z; Furie BC; Furie B; Andreasen PA; Huang M
    J Biol Chem; 2011 Mar; 286(9):7027-32. PubMed ID: 21199867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proteolytic activation of the human epithelial sodium channel by trypsin IV and trypsin I involves distinct cleavage sites.
    Haerteis S; Krappitz A; Krappitz M; Murphy JE; Bertog M; Krueger B; Nacken R; Chung H; Hollenberg MD; Knecht W; Bunnett NW; Korbmacher C
    J Biol Chem; 2014 Jul; 289(27):19067-78. PubMed ID: 24841206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incorporation of the δ-subunit into the epithelial sodium channel (ENaC) generates protease-resistant ENaCs in
    Wichmann L; Vowinkel KS; Perniss A; Manzini I; Althaus M
    J Biol Chem; 2018 May; 293(18):6647-6658. PubMed ID: 29576549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasmin and chymotrypsin have distinct preferences for channel activating cleavage sites in the γ subunit of the human epithelial sodium channel.
    Haerteis S; Krappitz M; Diakov A; Krappitz A; Rauh R; Korbmacher C
    J Gen Physiol; 2012 Oct; 140(4):375-89. PubMed ID: 22966015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cleavage in the {gamma}-subunit of the epithelial sodium channel (ENaC) plays an important role in the proteolytic activation of near-silent channels.
    Diakov A; Bera K; Mokrushina M; Krueger B; Korbmacher C
    J Physiol; 2008 Oct; 586(19):4587-608. PubMed ID: 18669538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmin in nephrotic urine activates the epithelial sodium channel.
    Svenningsen P; Bistrup C; Friis UG; Bertog M; Haerteis S; Krueger B; Stubbe J; Jensen ON; Thiesson HC; Uhrenholt TR; Jespersen B; Jensen BL; Korbmacher C; Skøtt O
    J Am Soc Nephrol; 2009 Feb; 20(2):299-310. PubMed ID: 19073825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A specific plasminogen activator inhibitor-1 antagonist derived from inactivated urokinase.
    Gong L; Proulle V; Fang C; Hong Z; Lin Z; Liu M; Xue G; Yuan C; Lin L; Furie B; Flaumenhaft R; Andreasen P; Furie B; Huang M
    J Cell Mol Med; 2016 Oct; 20(10):1851-60. PubMed ID: 27197780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aberrant glomerular filtration of urokinase-type plasminogen activator in nephrotic syndrome leads to amiloride-sensitive plasminogen activation in urine.
    Stæhr M; Buhl KB; Andersen RF; Svenningsen P; Nielsen F; Hinrichs GR; Bistrup C; Jensen BL
    Am J Physiol Renal Physiol; 2015 Aug; 309(3):F235-41. PubMed ID: 25972510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A peptide mimicking the C-terminal part of the reactive center loop induces the transition to the latent form of plasminogen activator inhibitor type-1.
    D'Amico S; Martial JA; Struman I
    FEBS Lett; 2012 Mar; 586(6):686-92. PubMed ID: 22449964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The delta-subunit of the epithelial sodium channel (ENaC) enhances channel activity and alters proteolytic ENaC activation.
    Haerteis S; Krueger B; Korbmacher C; Rauh R
    J Biol Chem; 2009 Oct; 284(42):29024-40. PubMed ID: 19717556
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Na+ inhibits the epithelial Na+ channel by binding to a site in an extracellular acidic cleft.
    Kashlan OB; Blobner BM; Zuzek Z; Tolino M; Kleyman TR
    J Biol Chem; 2015 Jan; 290(1):568-76. PubMed ID: 25389295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preferential assembly of epithelial sodium channel (ENaC) subunits in Xenopus oocytes: role of furin-mediated endogenous proteolysis.
    Harris M; Garcia-Caballero A; Stutts MJ; Firsov D; Rossier BC
    J Biol Chem; 2008 Mar; 283(12):7455-63. PubMed ID: 18195015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin E2 regulates production of plasminogen activator isoenzymes, urokinase receptor, and plasminogen activator inhibitor-1 in primary cultures of rat calvarial osteoblasts.
    Allan EH; Martin TJ
    J Cell Physiol; 1995 Dec; 165(3):521-9. PubMed ID: 7593231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 8-pCPT-cGMP stimulates alphabetagamma-ENaC activity in oocytes as an external ligand requiring specific nucleotide moieties.
    Nie HG; Zhang W; Han DY; Li QN; Li J; Zhao RZ; Su XF; Peng JB; Ji HL
    Am J Physiol Renal Physiol; 2010 Feb; 298(2):F323-34. PubMed ID: 20007351
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel form of the plasminogen activator inhibitor created by cysteine mutations extends its half-life: relevance to cancer and angiogenesis.
    Chorostowska-Wynimko J; Swiercz R; Skrzypczak-Jankun E; Wojtowicz A; Selman SH; Jankun J
    Mol Cancer Ther; 2003 Jan; 2(1):19-28. PubMed ID: 12533669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.